And a Once in a Decade Opportunity to Overweight EM Equity In the last decade, Emerging Markets equity performance has been lagging its U.S. counterparts by a significant 50% margin. Undoubtedly, part of this is contributed by the gain of = hot technology stocks in the U.S. (FAANG). However, currently U.S. earnings growth is peakingContinueContinue reading “The Case for Underweighting U.S. Equity”
Tag Archives: equity
May 2019: The Dollar Story and Where Are We in the Cycle?
Download PDF: Monthly_2019_April The strength of the dollar has dismayed many investors, us included. The weakening growth in the U.S., as measured by final demand component of the GDP, has pointed downward and should lead to a weaker dollar at a time when China is reflating. We still believe that the current improvement in EuroContinueContinue reading “May 2019: The Dollar Story and Where Are We in the Cycle?”
EM Country Overview: Mexico, Turkey, Brazil, South Africa, Russia
Download PDF: Q12019_LATAM_EMEA_Update A revisit of our investment thesis on emerging markets equities Mexico + (Overweight) Last year Mexican stocks were among the worst performer in the EM universe for two main reasons. First, the domestic economy is experiencing a sharp slowdown from industrial and oil production. Second, the increase in global risk aversion hasContinueContinue reading “EM Country Overview: Mexico, Turkey, Brazil, South Africa, Russia”
Lessons from Past Emerging Markets Cycles: Equity
PDF: Emerging Markets Review A Review of Emerging Markets Equity Performance Emerging markets equity is an inherently volatile asset class, with annual volatility of 17.7% compared to 14.2% for its developed markets counterpart. Investors who were willing to endure the higher risk has been rewarded tremendously in the long run. Between 1988 and today (SeptContinueContinue reading “Lessons from Past Emerging Markets Cycles: Equity”
Putamen Capital: February 2019 Update
Our decision last month to portfolio equity allocation proved to be a correct one, despite our model suggesting a very defensive position. Emerging Markets and U.S. equity rallied on the backdrop of Fed dovishness and signs of reflation coming from China, the largest importer for many EM countries. We still believe that the growth slowdownContinueContinue reading “Putamen Capital: February 2019 Update”
Putamen Capital: January 2019 Update
Our strategy last quarter to allocate small portion for equity paid off handsomely. Since we first launched our asset allocation model in October 2018, our model portfolio returned by 1.8% while our benchmark, MSCI ACWI, lost 6.0%. This month, the model recommends increasing the defensiveness of the portfolio by allocating 100% to bonds, a safe-havenContinueContinue reading “Putamen Capital: January 2019 Update”
World Equity Valuation, Profitability, and Solvency Ranking
This year proved to be a volatile one, starting with the volatility jump in February, which led to emerging markets turmoil. Argentina and Turkey have suffered from increasing inflationary pressure that was exacerbated by the plunging currency, and other emerging market countries have suffered too, albeit at a lower intensity. Chinese A-share has been beatenContinueContinue reading “World Equity Valuation, Profitability, and Solvency Ranking”
Equity Research Report: Telekomunikasi Indonesia 3Q17
Read better with the PDF file: TKM Report Telkom Indonesia: Cheap Valuation Despite Strong Performance Recommendation: BUY Target Price : Rp 5.580 Closing Price : Rp 4440 Upside (Downside) Potential : +25.8% Company Profile PT Telekomunikasi Indonesia Tbk offers telecommunications and network services. The Company’s segments include Corporate, Home, Personal and Others. TheContinueContinue reading “Equity Research Report: Telekomunikasi Indonesia 3Q17”
Equity Research Report: Metrodata Electronics 3Q17
Download the Report in PDF: MTDL Report METRODATA ELECTRONICS Tbk: Valuation MTDL.IJ (Indonesian Equity) Recommendation: BUY Target Price : Rp 930 Closing Price : Rp 595 Upside (Downside) Potential : 57.0% Company Profile PT Metrodata Electronics Tbk is an Indonesia-based information technology company. It is engaged in the provision of IT productsContinueContinue reading “Equity Research Report: Metrodata Electronics 3Q17”
Equity Research Report: Emergent Biosolutions 3Q17
Download the Report in PDF: EBS Report Download the Valuation in Excel: Emerging Biosolutions Valuation Emergent Biosolutions Inc.: 3Q17 Recommendation: BUY Target Price : $49.86 Closing Price : $40.86 Upside (Downside) Potential : 22.0% Company Profile Emergent BioSolutions Inc. develops, manufactures, and commercializes immunobiotics such as vaccines and immune globulins that assist the body’s immuneContinueContinue reading “Equity Research Report: Emergent Biosolutions 3Q17”
putamencapital.com 